BioAdaptives Statistics
Total Valuation
BioAdaptives has a market cap or net worth of 132,095. The enterprise value is 514,925.
| Market Cap | 132,095 |
| Enterprise Value | 514,925 |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioAdaptives has 12.01 million shares outstanding. The number of shares has increased by 26.42% in one year.
| Current Share Class | 12.01M |
| Shares Outstanding | 12.01M |
| Shares Change (YoY) | +26.42% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | n/a |
| Float | 11.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.55 |
| PB Ratio | -0.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.35 |
| EV / Sales | 21.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.99 |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.88 |
| Interest Coverage | -6.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -502.87% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 46.40% |
| Weighted Average Cost of Capital (WACC) | 22.72% |
| Revenue Per Employee | 23,792 |
| Profits Per Employee | -1.47M |
| Employee Count | 1 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 0.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.00% in the last 52 weeks. The beta is 1.43, so BioAdaptives's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -89.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 44.99 |
| Average Volume (20 Days) | 40,121 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioAdaptives had revenue of 23,792 and -1.47 million in losses. Loss per share was -0.14.
| Revenue | 23,792 |
| Gross Profit | 16,610 |
| Operating Income | -991,243 |
| Pretax Income | -1.47M |
| Net Income | -1.47M |
| EBITDA | -986,228 |
| EBIT | -991,243 |
| Loss Per Share | -0.14 |
Balance Sheet
The company has 73,606 in cash and 456,307 in debt, with a net cash position of -382,701 or -0.03 per share.
| Cash & Cash Equivalents | 73,606 |
| Total Debt | 456,307 |
| Net Cash | -382,701 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -2.14M |
| Book Value Per Share | -0.18 |
| Working Capital | -2.15M |
Cash Flow
In the last 12 months, operating cash flow was -502,958 and capital expenditures -18,000, giving a free cash flow of -520,958.
| Operating Cash Flow | -502,958 |
| Capital Expenditures | -18,000 |
| Depreciation & Amortization | 5,015 |
| Net Borrowing | 255,000 |
| Free Cash Flow | -520,958 |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | 69.81% |
| Operating Margin | -4,166.29% |
| Pretax Margin | -6,186.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioAdaptives does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.42% |
| Shareholder Yield | -26.42% |
| Earnings Yield | -1,114.23% |
| FCF Yield | -394.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 23, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jan 23, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |